Effects of Epalrestat on Peripheral Neuropathy and Central Nervous System in Diabetic Patients
Clinical trial NCT05184049 · UNKNOWN
Trial details
- NCT number
- NCT05184049
- Sponsor
- Xiangya Hospital of Central South University
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-01
- Primary completion
- 2023-10-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.